CompletedNot Applicable

A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis

Russia70 participantsStarted 2022-03-21

Plain-language summary

The goal of the interventional study is to assess the effectiveness of the supporting properties and safety of the dietary supplement ARTNEO (ARTNEO®), capsules with an average weight of 585 mg, in patients with osteoarthritis of the knee joint of both sexes aged 40 to 75 years. The main questions it aims to answer are: 1. To evaluate the effectiveness of the supporting properties of dietary supplement ARTNEO (ARTNEO®) in patients with knee osteoarthritis in comparison with active control; 2. To evaluate the safety of the dietary supplement ARTNEO (ARTNEO®) in patients with knee osteoarthritis

Who can participate

Age range40 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Hyaluronates - less than 6 months prior to randomization
✕. Other high molecular weight synovial fluid prostheses in less than 24 months
✕. Glucocorticosteroids - less than 1 month prior to randomization visit
✕. NSAIDs less than 3 weeks before randomization

What they're measuring

Change in the mean of the total score on The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale

Timeframe: Baseline to month 6

Trial details

NCT IDNCT06032442

SponsorNPO Petrovax

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-05-18

View on ClinicalTrials.gov More Osteoarthritis trials